Icescape‐scale metabolomics reveals cyanobacterial and topographic control of the core metabolism of the cryoconite ecosystem of an Arctic ice cap
Environmental Microbiology · 2023
DOI: 10.1111/1462-2920.16485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Microbiology, 2023. Verfasst von Jarishma K Gokul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Cledwyn Building, Aberystwyth University, Wales, UK. Hauptthemen laut MEDLINE: Cyanobacteria, Microbiota. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Great Britain Sasakawa Foundation, Natural Environment Research Council, Norges Forskningsråd.
Abstract (Originalsprache)
Glaciers host ecosystems comprised of biodiverse and active microbiota. Among glacial ecosystems, less is known about the ecology of ice caps since most studies focus on valley glaciers or ice sheet margins. Previously we detailed the microbiota of one such high Arctic ice cap, focusing on cryoconite as a microbe‐mineral aggregate formed by cyanobacteria. Here, we employ metabolomics at the scale of an entire ice cap to reveal the major metabolic pathways prevailing in the cryoconite of Foxfonna, central Svalbard. We reveal how geophysical and biotic processes influence the metabolomes of its resident cryoconite microbiota. We observed differences in amino acid, fatty acid, and nucleotide synthesis across the cap reflecting the influence of ice topography and the cyanobacteria within cryoconite. Ice topography influences central carbohydrate metabolism and nitrogen assimilation, whereas bacterial community structure governs lipid, nucleotide, and carotenoid biosynthesis processes. The prominence of polyamine metabolism and nitrogen assimilation highlights the importance of recycling nitrogenous nutrients. To our knowledge, this study represents the first application of metabolomics across an entire ice mass, demonstrating its utility as a tool for revealing the fundamental metabolic processes essential for sustaining life in supraglacial ecosystems experiencing profound change due to Arctic climate change‐driven mass loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Cledwyn Building, Aberystwyth University, Wales, UK.
- Department of Plant and Soil Sciences, University of Pretoria, Pretoria, South Africa.
- Department of Arctic Geology, University Centre in Svalbard (UNIS), Longyearbyen, Svalbard, Norway.
- Department of Environmental Sciences, Western Norway University of Environmental Science, Sogndal, Norway.
- Department of Geography and Earth Sciences, Aberystwyth University, Wales, UK.
- Department of Earth Sciences, Graduate School of Science, Chiba University, Chiba, Japan.
ORCID-Profile: Arwyn Edwards
Förderung
- Great Britain Sasakawa Foundation
- Natural Environment Research Council
- Norges Forskningsråd
Zitieren
APA
Gokul, J. K., Mur, L. A. J., Hodson, A. J., Irvine-Fynn, T. D. L., Debbonaire, A. R., Takeuchi, N., & Edwards, A. (2023). Icescape‐scale metabolomics reveals cyanobacterial and topographic control of the core metabolism of the cryoconite ecosystem of an Arctic ice cap. Environmental Microbiology. https://doi.org/10.1111/1462-2920.16485
Vancouver
Gokul JK, Mur LAJ, Hodson AJ, Irvine-Fynn TDL, Debbonaire AR, Takeuchi N, et al. Icescape‐scale metabolomics reveals cyanobacterial and topographic control of the core metabolism of the cryoconite ecosystem of an Arctic ice cap. Environmental Microbiology. 2023. doi:10.1111/1462-2920.16485
BibTeX
@article{Gokul2023,
author = {Gokul, Jarishma K and Mur, Luis A J and Hodson, Andrew J and Irvine-Fynn, Tristram D L and Debbonaire, Aliyah R and Takeuchi, Nozomu and Edwards, Arwyn},
title = {Icescape‐scale metabolomics reveals cyanobacterial and topographic control of the core metabolism of the cryoconite ecosystem of an Arctic ice cap},
journal = {Environmental Microbiology},
year = {2023},
doi = {10.1111/1462-2920.16485}
}
EUVIMED